弥漫大 B 细胞淋巴瘤（DLBCL）治疗面临挑战，研究人员探究过氧化物还原酶 1（PRDX1）对 DLBCL 铁死亡的作用及机制。发现 PRDX1 敲低可促进铁死亡、抑制 DLBCL 发展，为 DLBCL 治疗提供新策略。

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

Historically, bone has been recognized primarily for its structural role in the body, but emerging research suggests that it ...

Tobacco-based products, including e-cigarettes, have gained popularity as perceived safer alternatives to traditional smoking despite their addictive nature. However, emerging evidence shows that ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

结直肠癌（CRC）是全球第三常见的恶性肿瘤，也是癌症相关死亡的第二大原因。在确诊时，20%至25%的结直肠癌患者已出现远处转移，而在疾病进展过程中，近半数患者会发展为转移性疾病。转移性结直肠癌患者的五年生存率低于15%，而局限性疾病的五年生存率则超过 ...

肝细胞癌（HCC）治疗面临困境，现有疗法效果有限。研究人员开展了关于 L-741626 对 HCC 作用的研究。结果发现 L-741626 能抑制 HCC 进展，还可与索拉非尼协同增效。该研究为 HCC 治疗提供了新方向。

Total sales growth of 11.6% at CER1, or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from ...